#
Letrozole and ribociclib
  • Treatments
  • Breast Cancer

Letrozole and ribociclib

Generic name: letrozole and ribociclib [ LET-roe-zol-and-RYE-boe-SYE-klib ]
Brand names: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack 400 mg-2.5 mg Dose, Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Dosage form: oral tablet (2.5 mg-200 mg)
Drug class:Antineoplastic combinations

Medically reviewed by Drugs.com on Jul 14, 2020. Written by Cerner Multum.

What is letrozole and ribociclib?

Letrozole and ribociclib are used together in combination to treat HR-positive, HER2-negative breast cancer.

letrozole and ribociclib is used when the cancer has spread to other parts of the body (metastatic).

Letrozole and ribociclib are two different medicines that are packaged together. Letrozole tablets are yellow and ribociclib tablets are violet.

Letrozole and ribociclib may also be used for purposes not listed in this medication guide.

Warnings

This medicine can cause a serious heart rhythm or lung problem. Call your doctor at once if you have fast or pounding heartbeats, severe dizziness, chest pain, or shortness of breath.

Letrozole and ribociclib may also affect your liver or blood cells. Tell your doctor if you have right-sided stomach pain, tiredness, flu-symptoms, easy bruising or bleeding, dark urine, or yellowing of the skin or eyes.

This medicine may also cause a severe skin reaction. Get emergency medical help if you have a fever, sore throat, burning eyes, skin pain, or red or purple skin rash with blistering and peeling.

Before taking this medicine

You should not use letrozole and ribociclib if you are allergic to letrozole (Femara) or ribociclib (Kisqali).

Your doctor will perform medical tests to make sure you do not have conditions that would prevent you from safely using this medicine.

Tell your doctor if you have any signs of infection, such as fever or chills, or if you have ever had:

If you have not gone through menopause, you may need an additi...